4-Bromo-2-(pyridin-2-ylmethyl)pyridazin-3(2H)-one, >95%, 1g

4,6,8-Trimethylquinoline, 97%, 1g

TERT-BUTYL 4-(HYDROXYMETHYL)-4-PHENYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

(S)-DIETHYL 2-(TERT-BUTOXYCARBONYLAMINO)PENTANEDIOATE, 95.0%, 25g

1-Acetyl-2-amino-4,5-dihydro-4-oxo-1H-pyrrole-3-carbonitrile, 95.0%, 5g

tert-Butyl 3-fluoroazetidine-1-carboxylate, 5g

Aiguilles Pointe type 2 pour seringues GASTIGHT® série 1700, Gesch. pour, >= 250 μl, 6 pièces

Ethyl 5-amino-4H-[1,2,4]triazole-3-carboxylate, 97.0%, 25g

3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one, 98%, 5mg

3,5-Dimethoxy-4-hydroxybenzaldehyde, 95.0%, 100g

N-Ethylpropionamide, 98%, 100mg

4-{5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}pyridine dihydrochloride, 95.0%, 1g

5-Bromo-4-trifluoromethyl-pyridin-2-ol, 95.0%, 250mg